Close
4
Promoted Content
Promoted Content

Company profile for Sojournix

Client EmailClient Virtual Booth
SOJOURNIX
  • Connect with Us...

PharmaCompass
About the Company
Sojournix is a clinical stage biopharmaceutical company focused on developing and commercializing novel therapies for the treatment of women’s health and neuroendocrine disorders. We are developing SJX-653, a novel and selective neurokinin-3 (NK3) antagonist as a once-daily non-hormonal therapy for moderate to severe vasomotor symptoms (VMS or hot flashes) due to menopause. An estimated 6,000 U.S. women reach menopause eve...
Sojournix is a clinical stage biopharmaceutical company focused on developing and commercializing novel therapies for the treatment of women’s health and neuroendocrine disorders. We are developing SJX-653, a novel and selective neurokinin-3 (NK3) antagonist as a once-daily non-hormonal therapy for moderate to severe vasomotor symptoms (VMS or hot flashes) due to menopause. An estimated 6,000 U.S. women reach menopause every day (over two million per year) and the majority of these women experience vasomotor symptoms.
Upgrade the company profile

Upgrade this company profile// Update & customize all content.
Ask PharmaCompass, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
Sojournix
United_States_of_America Flag
Country
Country
UNITED STATES
Address
Address
400 Totten Pond Road Suite 110 Waltham, MA 02451
Telephone
Telephone
Linkedin
Linkedin
Twitter
Twitter
Client Virtual Booth

Upgrade this company profile// Update & customize all content.
Ask PharmaCompass, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Learn More About